SpineGuard revealed its 2017 full-year revenue.
Here are five key points:
1. The company saw revenue of $9.87 million in 2017, reflecting a 10 percent boost compared to that of 2016.
2. The company sold 8,764 Dynamic Surgical Guidance-enabled devices in 2017, compared to 8,603 in 2016.
3. Of the DSG-enabled devices sold, 5,303 sales occurred in the U.S., reflecting 61 percent of total sales. U.S. revenue increased 11 percent from the year prior.
4. The rest of the world saw revenue of approximately $1.8 million in 2017.
5. SpineGuard's CEO and Co-Founder Stéphane Bette noted the company is looking forward to introducing its "robotic application of DSG and the visual feedback capability" in 2018.